NasdaqGS - Nasdaq Real Time Price • USD
Codexis, Inc. (CDXS)
As of 10:14 AM EDT. Market Open.
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
-
-
Syntis Bio launches oral therapies for metabolic diseases
The company secured $15.5m in a seed funding round from investors in 2023.
Pharmaceutical Technology • 15 days ago -
-
-
-
-
-
Q1 2024 Codexis Inc Earnings Call
Q1 2024 Codexis Inc Earnings Call
Thomson Reuters StreetEvents • last month -
-
-
-
-
-
-
-
-
Q4 2023 Codexis Inc Earnings Call
Q4 2023 Codexis Inc Earnings Call
Thomson Reuters StreetEvents • 3 months ago -
-
-
Performance Overview
Trailing total returns as of 6/27/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | CDXS | S&P 500 |
---|---|---|
YTD | -0.98% | +15.07% |
1-Year | +13.96% | +26.79% |
3-Year | -86.60% | +28.22% |